Seeking Alpha

Johnson & Johnson's (JNJ +2.5%) subsidiary Cordis says European regulators and the FDA have...

Johnson & Johnson's (JNJ +2.5%) subsidiary Cordis says European regulators and the FDA have approved additional sizes for the company's Sleek OTW platform, an ultra-low profile percutaneous transluminal angioplasty dilatation catheter. The device is a highly deliverable balloon catheter designed to treat patients undergoing peripheral angioplasty procedures below the knee.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|